Hydroxychloroquine
Hydroxychloroquine is a pharmaceutical drug with 278 clinical trials. Currently 31 active trials ongoing. Historical success rate of 67.9%.
Success Metrics
Based on 114 completed trials
Phase Distribution
Phase Distribution
58
Early Stage
87
Mid Stage
96
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
59.7%
114 of 191 finished
40.3%
77 ended early
31
trials recruiting
278
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Hydrochloroquinine & Decitabine With Venetoclax in AML
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
Clinical Trials (278)
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Hydrochloroquinine & Decitabine With Venetoclax in AML
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma
Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Trial of Treatments for COVID-19 in Hospitalized Adults
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
The Danish Pre-HCQ COVID Dialysis Study
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 278